Encapsulation of Asparaginase as a Promising Strategy to Improve In Vivo Drug Performance


Por: Villanueva-Flores, Francisca, Zarate-Romero, Andres, Torres, Alfredo G., Huerta-Saquero, Alejandro

Publicada: 1 nov 2021
Categoría: Pharmaceutical science

Resumen:
Asparaginase (ASNase) is a widely applied chemotherapeutic drug that is used to treat Acute Lymphoblastic Leukemia (ALL); however, immune responses and silent inactivation of the drug often limit its bioavailability. Many strategies have been proposed to overcome these drawbacks, including the development of improved formulations (biobetters), but only two of them are currently on the market. Nano- and micro-encapsulation are some of the most promising and novel approaches to enhance in vivo performance of ASNase, preventing the direct contact of the enzyme with the environment, protecting it from protease degradation, increasing the enzymes catalytic half-life, and in some cases, reducing immunogenicity. This review summarizes the strategies, particularly for ASNase nano- and micro-encapsulation, and their main findings, constraints, and current gaps in the state-of-the-art knowledge. The pros and cons of the use of different nanocarriers are discussed with the idea to ultimately provide safer and more effective treatments for patients with ALL.

Filiaciones:
Villanueva-Flores, Francisca:
 Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Km. 107 Carretera Tijuana-Ensenada, Ensenada, 22860, Mexico

Zarate-Romero, Andres:
 Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Km. 107 Carretera Tijuana-Ensenada, Ensenada, 22860, Mexico

Torres, Alfredo G.:
 Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77550, United States

Huerta-Saquero, Alejandro:
 Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Km. 107 Carretera Tijuana-Ensenada, Ensenada, 22860, Mexico

 Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77550, United States
ISSN: 19994923





Pharmaceutics
Editorial
MDPI AG, ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND, Suiza
Tipo de documento: Review
Volumen: 13 Número: 11
Páginas:
WOS Id: 000727516800001
ID de PubMed: 34834379
imagen Green Published, gold, All Open Access; Gold

MÉTRICAS